Search research articles
Contact Us
Filters
Showing results (21-30 of 69) with videos related to
Page
of 7
Sort By:
Cancer Research
|
February 1, 1990
Radiolocalization of monoclonal antibodies in hepatic metastases from human colon cancer in congenitally athymic mice
K Yoshida, M Rivoire, C Divgi, et al.
Cancer Research
|
September 18, 2001
Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33
G Ritter, L S Cohen, C Williams, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 1, 1995
New pancreas cancers cell lines that represent distinct stages of ductal differentiation
M R Vilá, J Lloreta, M H Schüssler, et al.
Oncotarget
|
October 13, 2016
Specificity and biologic activities of novel anti-membrane IgM antibodies
Rachel S Welt, Jonathan A Welt, David Kostyal, et al.
Carbohydrate Research
|
July 15, 1988
Analysis of a mouse monoclonal antibody detecting the H type 1 blood group determinant
S Welt, B W Yin, K Furukawa, et al.
Nuclear Medicine and Biology
|
March 9, 2000
High yield direct 76Br-bromination of monoclonal antibodies using chloramine-T
J Sundin, V Tolmachev, J Koziorowski, et al.
International Journal of Cancer
|
December 15, 1989
Expression of TAG-72 in normal colon, transitional mucosa, and colon cancer
M Xu, F X Real, S Welt, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
December 1, 1991
Some monoclonal antibody reagents (C219 and JSB-1) to P-glycoprotein contain antibodies to blood group A carbohydrate determinants: a problem of quality control for immunohistochemical analysis
C L Finstad, B W Yin, C M Gordon, et al.
Molecular Immunology
|
August 1, 1990
Analysis of the fine specificities of 11 mouse monoclonal antibodies reactive with type 2 blood group determinants
K Furukawa, S Welt, B W Yin, et al.
Cancer Research
|
June 1, 1997
Enhanced antitumor activity of combination radioimmunotherapy (131I-labeled monoclonal antibody A33) with chemotherapy (fluorouracil)
J Tschmelitsch, E Barendswaard, C Williams, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 69) with videos related to
Sort By:
Page
of 7
Cancer Research
|
February 1, 1990
Radiolocalization of monoclonal antibodies in hepatic metastases from human colon cancer in congenitally athymic mice
K Yoshida, M Rivoire, C Divgi, et al.
Cancer Research
|
September 18, 2001
Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody A33
G Ritter, L S Cohen, C Williams, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 1, 1995
New pancreas cancers cell lines that represent distinct stages of ductal differentiation
M R Vilá, J Lloreta, M H Schüssler, et al.
Oncotarget
|
October 13, 2016
Specificity and biologic activities of novel anti-membrane IgM antibodies
Rachel S Welt, Jonathan A Welt, David Kostyal, et al.
Carbohydrate Research
|
July 15, 1988
Analysis of a mouse monoclonal antibody detecting the H type 1 blood group determinant
S Welt, B W Yin, K Furukawa, et al.
Nuclear Medicine and Biology
|
March 9, 2000
High yield direct 76Br-bromination of monoclonal antibodies using chloramine-T
J Sundin, V Tolmachev, J Koziorowski, et al.
International Journal of Cancer
|
December 15, 1989
Expression of TAG-72 in normal colon, transitional mucosa, and colon cancer
M Xu, F X Real, S Welt, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
December 1, 1991
Some monoclonal antibody reagents (C219 and JSB-1) to P-glycoprotein contain antibodies to blood group A carbohydrate determinants: a problem of quality control for immunohistochemical analysis
C L Finstad, B W Yin, C M Gordon, et al.
Molecular Immunology
|
August 1, 1990
Analysis of the fine specificities of 11 mouse monoclonal antibodies reactive with type 2 blood group determinants
K Furukawa, S Welt, B W Yin, et al.
Cancer Research
|
June 1, 1997
Enhanced antitumor activity of combination radioimmunotherapy (131I-labeled monoclonal antibody A33) with chemotherapy (fluorouracil)
J Tschmelitsch, E Barendswaard, C Williams, et al.
Page
of 7